Methods and uses for molecular tags
Methods and uses for molecular tags are disclosed. Molecular tags may be attached to nucleic acid molecules. The attachment of the nucleic acid molecules prior to PCR amplification and sequencing improves the accuracy of genetic analysis and detection of genetic variations and diversity. Molecular tags may also be used for detection of drug-resistant variants. Methods for using molecular tags for determining and correcting PCR errors and/or sequencing error are also disclosed.
1. A method for detecting variants in a plurality of nucleic acid molecules comprising:
(a) attaching a plurality of primers comprising a target specific sequence and a Primer ID, wherein the Primer ID further comprises a predetermined sequence, to a plurality of nucleic acid molecules in a sample, comprising a complex population, to generate tagged-nucleic acid templates, wherein (i) the plurality of nucleic acid molecules comprises 10 or more different nucleic acid templates wherein the different nucleic acid templates comprise nucleotide variants, and (ii) each tagged nucleic acid template is attached to a unique Primer ID;
(b) amplifying the tagged nucleic acid templates to produce tagged amplicons; and
(c) detecting the tagged amplicons, thereby detecting variants, wherein the method is capable of detecting variants present in less than 20% frequency in the complex population, in the plurality of nucleic acid molecules, wherein detecting the plurality of nucleic acid molecules comprises determining, with the aid of a computer processor, (i) PCR resampling in an amplification reaction; or (ii) a PCR error rate and/or sequencing error rate, wherein determining the PCR error rate and/or sequencing error rate comprises determining fidelity of a polymerase.
2. A method for detecting variants in a plurality of nucleic acid molecules comprising:
(a) attaching a plurality of primers comprising a target specific sequence and a Primer ID, wherein the Primer ID further comprises a predetermined sequence, to a plurality of nucleic acid molecules in a sample, comprising a complex population, to generate tagged-nucleic acid templates, wherein (i) the plurality of nucleic acid molecules comprises 10 or more different nucleic acid templates wherein the different nucleic acid templates comprise nucleotide variants, and (ii) each tagged nucleic acid template is attached to a unique Primer ID;
(b) amplifying the tagged nucleic acid templates to produce tagged amplicons; and
(c) detecting the tagged amplicons, thereby detecting variants, wherein the method is capable of detecting variants present in less than 20% frequency in the complex population, in the plurality of nucleic acid molecules, wherein detecting the plurality of nucleic acid molecules comprises determining, with the aid of a computer processor, (i) PCR resampling in an amplification reaction; or (ii) a PCR error rate and/or sequencing error rate, wherein determining the PCR error rate and/or sequencing error rate comprises determining accuracy of oligonucleotides synthesized in vitro.
3. A method for detecting variants in a plurality of nucleic acid molecules comprising:
(a) attaching a plurality of primers comprising a target specific sequence and a Primer ID, wherein the Primer ID further comprises a predetermined sequence, to a plurality of nucleic acid molecules in a sample, comprising a complex population, to generate tagged-nucleic acid templates, wherein (i) the plurality of nucleic acid molecules comprises 10 or more different nucleic acid templates wherein the different nucleic acid templates comprise nucleotide variants, and (ii) each tagged nucleic acid template is attached to a unique Primer ID;
(b) amplifying the tagged nucleic acid templates to produce tagged amplicons; and
(c) detecting the tagged amplicons, thereby detecting variants, wherein the method is capable of detecting variants present in less than 20% frequency in the complex population, in the plurality of nucleic acid molecules, wherein detecting the plurality of nucleic acid molecules comprises determining, with the aid of a computer processor, (i) PCR resampling in an amplification reaction; or (ii) a PCR error rate and/or sequencing error rate, wherein determining the PCR error rate and/or sequencing error rate comprises determining accuracy of a sequencing reaction.
4. The method of claim 3 , wherein detecting the tagged amplicons comprises sequencing the tagged amplicons.
5. The method of claim 3 , wherein detecting the tagged amplicons further comprises counting a number of different Primer IDs associated with the tagged amplicons, wherein the number of different Primer IDs associated with the tagged amplicons reflects the number of templates sampled.
6. The method of claim 3 , further comprising forming a consensus sequence for tagged amplicons comprising the same Primer ID.
7. The method of claim 3 , wherein the nucleic acid template comprises a DNA template.
8. The method of claim 3 , wherein the nucleic acid template comprises an RNA template.
9. The method of claim 3 , wherein the nucleic acid template comprises a non-viral template.
10. The method of claim 3 , wherein the nucleic acid template molecules comprise a viral sequence or a bacterial sequence.
11. The method of claim 3 , wherein the sample is from an individual suffering from a viral infection, a bacterial infection, a cancer, or an autoimmune disorder.
12. The method of claim 3 , wherein the Primer ID comprises a degenerate sequence.
13. The method of claim 3 , wherein the Primer ID is attached to the template by ligation, hybridization, or PCR.
14. The method of claim 3 , wherein amplifying comprises a PCR-based method.
15. The method of claim 14 , wherein the PCR-based method is selected from the group consisting of PCR, quantitative PCR, emulsion PCR, droplet PCR, hot start PCR, multiplex PCR, nested PCR and semi-nested PCR.
16. The method of claim 3 , wherein the Primer ID comprises 5-100 nucleotides.
17. The method of claim 3 , wherein the Primer ID comprises 5-50 nucleotides.
18. The method of claim 3 , wherein the Primer ID comprises at least 8 nucleotides.
19. The method of claim 3 , wherein the method is capable of detecting variants present in less than 2.5% of the complex population.
20. The method of claim 3 , wherein the method is capable of detecting variants present in less than 1% of the complex population.
21. The method of claim 3 , wherein the plurality of nucleic acid templates comprise at least 50 different nucleic acid templates.
22. The method of claim 3 , wherein the plurality of nucleic acid templates comprise at least 200 different nucleic acid templates.
23. The method of claim 3 , wherein the plurality of nucleic acid templates comprise at least 500 different nucleic acid templates.
24. The method of claim 3 , wherein the plurality of primers comprising the target specific sequence and the Primer ID are attached to the plurality of nucleic acid molecules in the sample by primer extension.